Salts and polymorphs of certain MCL-1 inhibitors | Patent Number 12162896

US 12162896 B2
Application Number18311708
Publication NumberUS 20230357274 A1
Pendency1 year, 7 months, 12 days
Filled DateMay 3, 2023
Priority DateMay 4, 2022
Publication DateNov 9, 2023
Expiration DateMay 3, 2042
Inventor/ApplicantsChristopher S. Regens
John Enquist
David A. Siler
Michael A. Ischay
Sarah E. Wortman
Olga V. Lapina
David W. Lin
Eric A. Standley
ExaminesWHITE, DAWANNA SHAR-DAY
Art Unit1627
Technology Center1600
Assignments
Gilead Sciences
Current
Gilead Sciences
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.